WAP domain proteins as modulators of mucosal immunity
Open Access
- 21 September 2011
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 39 (5), 1409-1415
- https://doi.org/10.1042/bst0391409
Abstract
WAP (whey acidic protein) is an important whey protein present in milk of mammals. This protein has characteristic domains, rich in cysteine residues, called 4-DSC (four-disulfide core domain). Other proteins, mainly present at mucosal surfaces, have been shown to also possess these characteristic WAP-4-DSC domains. The present review will focus on two WAP-4-DSC containing proteins, namely SLPI (secretory leucocyte protease inhibitor) and trappin-2/elafin. Although first described as antiproteases able to inhibit in particular host neutrophil proteases [NE (neutrophil elastase), cathepsin-G and proteinase-3] and as such, able to limit maladaptive tissue damage during inflammation, it has become apparent that these molecules have a variety of other functions (direct antimicrobial activity, bacterial opsonization, induction of adaptive immune responses, promotion of tissue repair, etc.). After providing information about the ‘classical’ antiproteasic role of these molecules, we will discuss the evidence pertaining to their pleiotropic functions in inflammation and immunity.Keywords
This publication has 89 references indexed in Scilit:
- Secretory Leukocyte Protease InhibitorAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Secretory Leucoprotease Inhibitor Prevents Lipopolysaccharide-induced IκBα Degradation without Affecting Phosphorylation or UbiquitinationPublished by Elsevier BV ,2002
- Binding of human secretory leukocyte protease inhibitor in uterine cervical mucus to immunoglobulins: pathophysiology in immunologic infertility and local immune defenseFertility and Sterility, 1999
- Inhibition of NF-κB Activation and Augmentation of IκBβ by Secretory Leukocyte Protease Inhibitor during Lung InflammationThe American Journal of Pathology, 1999
- Structure of the Murine Secretory Leukoprotease Inhibitor (Slpi) Gene and Chromosomal Localization of the Human and Murine SLPI GenesAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Interaction of Secretory Leukocyte Protease Inhibitor with Heparin Inhibits Proteases Involved in AsthmaPublished by Elsevier BV ,1998
- Inhibition by recombinant SLPI and half‐SLPI (Asn55‐Ala107) of elastase and cathepsin G activities: consequence for neutrophil‐platelet cooperationBritish Journal of Pharmacology, 1993
- Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domainBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteasesNucleic Acids Research, 1986
- Comparison of the whey acidic protein genra of the rat and mouseNucleic Acids Research, 1984